Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | peroxisome proliferator-activated receptor gamma | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | ecdysone induced protein 78C | peroxisome proliferator-activated receptor gamma | 477 aa | 447 aa | 28.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.2684 | 0.3489 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.4997 | 0.4997 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0036 | 0.3109 | 0.3109 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0036 | 0.3109 | 0.3109 |
Echinococcus multilocularis | sodium channel protein | 0.0036 | 0.3188 | 0.3188 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0036 | 0.3109 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.4649 | 0.6043 |
Echinococcus granulosus | voltage gated sodium channel Nav1 alpha subunit | 0.0036 | 0.3188 | 0.3188 |
Echinococcus granulosus | sodium channel protein | 0.0036 | 0.3188 | 0.3188 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.2962 | 0.2962 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.9662 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.2684 | 0.2778 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0081 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.4649 | 0.4811 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0036 | 0.3109 | 0.4042 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.3109 | 0.3218 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.4997 | 0.5171 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.3109 | 0.3109 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.4649 | 0.4649 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.4649 | 0.6043 |
Echinococcus multilocularis | jun protein | 0.0081 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0064 | 0.7356 | 0.7356 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.3109 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.4649 | 0.4649 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.4649 | 0.4649 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.4649 | 0.6043 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0081 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.7693 | 1 |
Schistosoma mansoni | jun-related protein | 0.0066 | 0.7693 | 1 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.0036 | 0.3188 | 1 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.3109 | 0.3109 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.2962 | 0.2962 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.4997 | 0.5171 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0036 | 0.3109 | 0.5 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0036 | 0.3109 | 0.3109 |
Brugia malayi | hypothetical protein | 0.0035 | 0.2962 | 0.2962 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.3109 | 0.3109 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.2684 | 0.2684 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.4997 | 0.4997 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.3109 | 0.3109 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.2962 | 0.385 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.3109 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.4649 | 0.4649 |
Echinococcus granulosus | jun protein | 0.0081 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.4649 | 0.4649 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.2962 | 0.385 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0036 | 0.3109 | 0.5 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0036 | 0.3109 | 0.4042 |
Onchocerca volvulus | 0.0064 | 0.7356 | 0.5 | |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.3109 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0036 | 0.3109 | 0.5 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0036 | 0.3109 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | > 30 uM | Transactivation of GAL4 DBD-fused human PPARgamma-LBD expressed in HEK293 cells after 24 hrs by luciferase reporter gene assay | ChEMBL. | 23294830 |
Efficacy (binding) | = 0 % | Transactivation of GAL4 DBD-fused human PPARgamma-LBD expressed in HEK293 cells after 24 hrs by luciferase reporter gene assay relative to rosiglitazone | ChEMBL. | 23294830 |
IC50 (binding) | > 10 uM | Displacement of [3H]-rosiglitazone from GST-tagged PPARgammaLBD (unknown origin) after 1 hr by scintillation proximity assay | ChEMBL. | 23294830 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.